Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $12.80 million. The enterprise value is $6.48 million.

Market Cap	12.80M
Enterprise Value	6.48M

Important Dates

The next estimated earnings date is Friday, March 20, 2026, after market close.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	n/a

Share Statistics

MBRX has 5.20 million shares outstanding. The number of shares has increased by 528.05% in one year.

Current Share Class	5.20M
Shares Outstanding	5.20M
Shares Change (YoY)	+528.05%
Shares Change (QoQ)	+135.60%
Owned by Insiders (%)	0.85%
Owned by Institutions (%)	3.06%
Float	3.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.39

Current Ratio	1.39
Quick Ratio	1.18
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-69.18%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-165.04%
Weighted Average Cost of Capital (WACC)	13.03%
Revenue Per Employee	n/a
Profits Per Employee	-$3.02M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.44% in the last 52 weeks. The beta is 1.67, so MBRX's price volatility has been higher than the market average.

Beta (5Y)	1.67
52-Week Price Change	-94.44%
50-Day Moving Average	4.20
200-Day Moving Average	11.59
Relative Strength Index (RSI)	27.76
Average Volume (20 Days)	220,936

Short Selling Information

The latest short interest is 429,080, so 8.25% of the outstanding shares have been sold short.

Short Interest	429,080
Short Previous Month	358,088
Short % of Shares Out	8.25%
Short % of Float	14.14%
Short Ratio (days to cover)	2.16

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.21M
Pretax Income	-51.41M
Net Income	-51.41M
EBITDA	-24.10M
EBIT	-24.21M
Earnings Per Share (EPS)	-$76.14

Balance Sheet

The company has $6.70 million in cash and $390,000 in debt, with a net cash position of $6.31 million or $1.21 per share.

Cash & Cash Equivalents	6.70M
Total Debt	390,000
Net Cash	6.31M
Net Cash Per Share	$1.21
Equity (Book Value)	-26.92M
Book Value Per Share	-13.60
Working Capital	2.20M

Cash Flow

Operating Cash Flow	-22.45M
Capital Expenditures	n/a
Free Cash Flow	-22.45M
FCF Per Share	-$4.32

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-528.05%
Shareholder Yield	-528.05%
Earnings Yield	-401.75%
FCF Yield	-175.45%

Analyst Forecast

The average price target for MBRX is $105.50, which is 4,188.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$105.50
Price Target Difference	4,188.62%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 1, 2025. It was a reverse split with a ratio of 1:25.

Last Split Date	Dec 1, 2025
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1